ARL

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on May 30, 2012 has recommended a dividend @ 7% viz. Rs. 0.70 paise per equity share of Rs. 10 each, subject to the approval of the shareholders in the Annual General Meeting.

Arvind Remedies Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2012.

Members of the Exchange are hereby informed that the trading in equity shares of Arvind Remedies Limited shall be suspended w.e.f. May 14, 2012 (i.e. closing hours of trading on May 11, 2012) on account of Consolidation of equity shares from Re.1/- to Rs.10/-.

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on April 28, 2012 have approved appointment of following persons as Executive Directors on the Board subject to the approvals of shareholders in the General Meeting. (1) Mr. Ankur Agarwal as Executive Director (Technical) with effect from April 18, 2012. (2) Dr. Raghuveer as Executive Director (Operations) from April 28, 2012.

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on April 28, 2012 have fixed the record date for consolidation of the equity shares of the Company from Re.1 each to Rs.10 per share as May 15, 2012.

Arvind Remedies Limited has submitted to the Exchange a Copy of proceedings of the Extra Ordinary General Meeting of the members of the Company held on April 28, 2012.

Arvind Remedies Limited has informed the Exchange that it has been decided by the Board of Directors that the company will publish the audited financial results for the quarter and year ended March 31, 2012 within 60 days of the close of the financial year.

Arvind Remedies Limited has submitted to the Exchange a copy of the notice of the Extraordinary General Meeting of the Members of the Company to be held on April 28, 2012.

Arvind Remedies Limited has submitted to the Exchange vide its letter dated March 13, 2012 a copy of disclosure pursuant to Regulation 13(4) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results along with Limited Review Report for the period ended December 31,2011.

Arvind Remedies Limited has informed the Exchange regarding the Outcome of the Board of Directors of the Company at its meeting held on February 11, 2012.

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 05, 2011 discussed and approved the consolidation of the existing equity shares from Re.1 to Rs.10/- and it was decided to obtain consent of the Shareholders for the same and that due procedures as required be completed in this regard.

Arvind Remedies Limited has submitted to the Exchange a copy of the notice of the Extraordinary General Meeting of the Members of the Company scheduled to be held on November 05, 2011.

Arvind Remedies Limited has submitted to the Exchange a copy of the Minutes of the Annual General Meeting of the Members of the Company held on September 19, 2011.

Arvind Remedies Limited has submitted to the Exchange a copy of Disclosure under Regulation 7(3) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 1997.

Arvind Remedies Limited has informed to the Exchange that the Annual General Meeting of the Members of the company to be held on September 19, 2011.

Arvind Remedies Limited has submitted to the Exchange a copy of the Disclosure under SEBI (Substantial Acquisition of Shares & Takeovers ) Regulations, 1997.

Arvind Remedies Limited has informed the Exchange that in the Meeting of Board of Directors of the Company held on August 02, 2011, following items were considered : 1) Board approved the proposal to acquire an existing manufacturing company engaged in a similar line of business at an overall consideration of Rs. 11 Crores. 2) The notice convening the Annual General Meeting was approved and it was decided to include the following items as special business i) Conversion of the preference share capital into the equity share capital . ii) Amendment of the existing Articles of Association of the C

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2011.

Arvind Remedies Limited has informed the Exchange that the Company has fixed the book closure dates from September 16, 2011 to September 19, 2011 (both days inclusive) for the purpose of payment of dividend.

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 23, 2011 has recommended a dividend @ 7% on equity share (i.e. Rs.0.07 per share) on pro-rata basis subject to approval of the members in the Annual General Meeting.

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2011.

Arvind Remedies Limited has informed the Exchange that on appointment of new directors there has been change in the Board of Directors of the Company as per detail given below: (1) Appointment as Additional Directors: (i) Mr. V. R Mehta (ii) Mr. Akshay Shah (2) Resignation from directorship: Mr. Prakash Shah.

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2010.

Arvind Remedies Limited has informed the Exchange that in the Meeting of Board of Directors of the Company held on January 5, 2011, the Board approved allotment of 22,22,50,000 equity shares issued on preferential basis, to Dr. Arvind Kumar B Shah HUF, M/s. Narit Tradecom Pvt Ltd. and M/s. Aryaman Commerce P Ltd. from whom the company has received the consideration @ Re. 1.00 each with premium of Rs. 1.25 per share.

Arvind Remedies Limited has informed the Exchange that the Company has appointed Mr. S.V. Sundara Raman as Chief Financial Officer of the Company. Mr. Sundara Raman is a Fellow Chartered Accountant and has worked for 32 years in various fields in India and abroad. He has joined his duties from December 30, 2010.

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company, in the meeting held on November 13, 2010, have approved appointing Mr.Raja Mohan as Additional Director of the Company in place of Dr.Yogesh Kothari who had resigned earlier.

Arvind Remedies Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2010.

Arvind Remedies Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Members of the Company held on September 28, 2010.

Arvind Remedies Limited has informed the Exchange that in the Board meeting held on August 31, 2010 the following decisions were taken: (1) It was decided to hold the Annual General Meeting of the Company on September 28, 2010, (2) It was decided to include the following items as special business in the Notice of AGM: a) Reappointment of Dr. B Arvind Shah as Managing Director for further five years pursuant to Section 198, 309 and Schedule XIII of the Companies Act. b) Appointment of Mr. Anand Shah as Vice President, subject to approval of Central Government for payment of remuneration pursuan

Arvind Remedies Limited has informed the Exchange that the Board of Directors at its meeting held on August 31, 2010 decided to close the Register of Members and Register of Share transfer from September 25, 2010 to September 28, 2010 (both days inclusive) for the purpose of Annual General Meeting and for payment of dividend.

Arvind Remedies Limited has informed the Exchange that the Board of Directors at its meeting held on May 29, 2010 recommended dividend @ 5 paise per equity share (5% on Re. 1 share).

Arvind Remedies Limited had informed the Exchange that "We will be publishing the audited financial results for the quarter and year ended 31st March 2010 on or before June 30, 2010 i.e. within three months from the end of the last quarter". The Company has now informed the Exchange that in view of the recent amendments, it has been decided that the Company will be publishing the audited financial results by May 30, 2010.

Arvind Remedies Limited has informed the Exchange that Mr. Kuppu Dhandapani, who was appointed as Chief Finance Officer of the Company submitted his resignation which has been accepted by the Company and he is relieved from the services effective from March 18, 2010 Mr. Dhandapani had joined the services of the Company in the month of April 2009.

Arvind Remedies Limited has informed the Exchange that: "We will be publishing the audited financial results for the quarter and year ended 31st March 2010 on or before June 30, 2010 i.e. within three months from the end of the last quarter".

Arvind Remedies Limited has has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on October 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ArvindRem_AGMProc_04112009.zip target=NEW> For more details click here.</a>

Arvind Remedies Limited has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956, the results of the following resolutions taken by way of postal ballot were declared to have passed on October 19, 2009 based on the report given by the scrutinizer. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/arl_rpb_23102009.zip target=NEW> For more details click here.</a>

Arvind Remedies Limited has informed the Exchange that in the Board Meeting of the Company held on September 29, 2009 following decisions were taken. (1) It was decided that the Annual General Meeting of the Company be held on October 30, 2009 the draft notice with agenda was approved. (2) It was decided that the Register of Members be closed from October 27, to October 30, 2009 (both days inclusive) for the purpose of AGM and payment of dividend.

Arvind Remedies Limited has informed the Exchange regarding the outcome of the Board Meeting held on September 07, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/arvind_outcome_10092009.zip target=NEW> For more details click here.</a>

Arvind Remedies Limited has informed the Exchange that the company has appointed Mr. K. Kuppu Dhandapani as Chief Financial Officer of the company. Earlier, Mr. Nirajkumar Ganeriwal, was the Financial Controller of the company who resigned from the services from March 2009.

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 30, 2009 the Board discussed that : (a) due to changes in the fiscal policies, the benefits available on the Hardiwar unit have been substantially reduced and hence not to pursue with the project. (b) For the proposed new project near Chennai, the project feasibility report be obtained and placed in the next Board meeting for decision. The funding of the project will also be discussed in that meeting. Resultantly, the proposed resolutions u/s 94 for increasing authorized shar

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 30, 2009 have recommended a dividend on Equity Shares @ 5 paise per share subject to the approval of members.

Arvind Remedies Limited has informed the Exchange that the Company will be publishing the audited financial results for the quarter and year ended March 31, 2009 on or before June 30, 2009 i.e. within three months from the end of the last quarter.

Arvind Remedies Limited had informed the Exchange regarding proposal for preferential issue of equity shares to Dr. Arvind B Shah and fixing the date of Extra Ordinary General Meeting on May 02, 2009 for the same. The Company has now informed the Exchange that, since approval from SEBI on the application submitted by the acquirer (promoter) for exemption from SEBI (SAST) Regulations, 1997 has been pending before SEBI, it has been decided by the Board of Directors in its meeting held on April 7, 2009 that the EGM be deferred to a later date till receipt of the approval. Accordingly the new date

Arvind Remedies Limited has informed the Exchange that the Board of Directors at their meeting held on March 28, 2009, considered the Preferential Issue of equity shares to Dr. Arvind Kumar B Shah (HUF) on conversion of the unsecured loan given by him into equity. While taking this decision it was felt that based on the application to SEBI for giving in-principal approval, it may await for the same as the promoter has already submitted necessary application for exemption from SEBI (SAST) Regulations, 1997 which was pending before SEBI. Accordingly, subject to the approval by SEBI, it was dec

Arvind Remedies Limited has informed the Exchange that as per SEBI Notification dated 28th January 2009 of SEBI (SAST) (Amendments) Regulations 2009, the Company has been informed by promoters of the Company that no equity share of the Company held by them have been pledge till date. (February 10, 2009.)

Arvind Remedies Limited has informed the Exchange that in the meeting of Board of Directors of the Company held on October 31, 2008, following two Directors were appointed as Additional Director. Mr. Prakash Kumar Shah, Dr. Yogesh Kothari. Board also considered the resignation letters received from following 2 Directors and accepted the same. Mr. S. B Shah, Mr. Chotalal.

Arvind Remedies Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on September 29, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ARL_AGM_30092008.zip target=NEW> For more details click here.</a>

Arvind Remedies Limited has informed the Exchange that: "Mr. V. Viswanathan has resigned from our service as Company Secretary, and our new Company Secretary is Mr. P.R. Krishnan".